New Tuberculosis treatment could save millions of lives
New Tuberculosis (TB) drug that will shorten the treatment of the disease by up to two months, potentially saving millions of lives.
New Tuberculosis (TB) drug that will shorten the treatment of the disease by up to two months, potentially saving millions of lives.
New medical advances could revolutionise the ability to treat undetected tuberculosis (TB).
St Andrews scientists are leading the medical monitoring of a new clinical trial to treat tuberculosis more quickly.
Medical research charity LifeArc and the University Infection Group will partner up to develop a molecular diagnostic test for TB.
A new breakthrough will cut the time needed to diagnose tuberculosis to save hundreds of thousands of lives in emerging countries.
St Andrews scientists say international effort yields ‘important’ results
Launch of a new data platform shares the results of major TB drug trials led by the University of St Andrews.
St Andrews receives funding from the European and Developing Countries Clinical Trials Partnership to progress the fight against TB.
A new video game from Abertay University students and University of St Andrews scientists tackles tuberculosis
University marks World TB Day in ground breaking tuberculosis trial